Novel Antischizophrenia Treatments edited by Mark A. Geyer, Gerhard Gross.

This volume tries to put current therapy - achievements, shortcomings, remaining medical needs - and emerging new targets into the context of increasing knowledge regarding the genetic and neurodevelopmental contributions to the pathophysiology of schizophrenia. Some of the chapters also deal with r...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Geyer, Mark A. (Editor), Gross, Gerhard (Editor)
Format: eBook
Language:English
Published: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2012.
Edition:1st ed. 2012.
Series:Handbook of Experimental Pharmacology, 213
Springer eBook Collection.
Subjects:
Online Access:Click to view e-book
Holy Cross Note:Loaded electronically.
Electronic access restricted to members of the Holy Cross Community.
Table of Contents:
  • Preface
  • Clinical instruments to evaluate and guide treatment in schizophrenia
  • Cognitive deficits in schizophrenia- Muscarinic mechanisms in psychotic disorders
  • Nicotinic mechanisms in psychotic disorders
  • GABAergic circuits in schizophrenia: targets for new treatments in schizophrenia
  • Inhibitors of glycine transport as potential new treatments in schizophrenia
  • The role of glutamate in schizophrenia
  • Metabotropic glutamate receptors as targets for new treatments in schizophrenia
  • 5-HT2C agonism as a principle for new treatments in schizophrenia.- The role of dopamine D3 receptors for antipsychotic activity and cognitive functions
  • Phosphodiesterase inhibitors as potential new treatments in schizophrenia
  • Disease modifying approaches to schizophrenia
  • A novel therapeutic strategy: medication-enhancement of cognitive therapies in schizophrenia
  • Transgenic animals reflecting aspects of schizophrenia
  • Behavioral animal models of pro-cognitive treatments for schizophrenia. .